ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

MIRO MiroMatrix Medical Inc

3.39
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
MiroMatrix Medical Inc MIRO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 3.39 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.39
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/12/202305:02EDGAR2Form 15-12G - Securities registration termination [Section..
18/12/202315:30EDGAR2Form 8-K - Current report
17/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/12/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202309:14EDGAR2Form POS AM - Post-Effective amendments for registration..
13/12/202309:13EDGAR2Form S-8 POS - Securities to be offered to employees in..
13/12/202309:03EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
13/12/202308:15BWUnited Therapeutics and Miromatrix Medical Announce..
12/12/202310:22EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/12/202305:00BWUnited Therapeutics and Miromatrix Medical Announce..
07/12/202315:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/11/202316:14EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/11/202315:05GLOBEMiromatrix Reports Third Quarter 2023 Results
14/11/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202306:01EDGAR2Form SC 14D9 - Solicitation, recommendation statements
30/10/202306:03EDGAR2Form SC14D9C - Written communication relating to third party..
30/10/202305:12EDGAR2Form 8-K - Current report
30/10/202305:05GLOBEUnited Therapeutics to Acquire Miromatrix Medical
30/10/202305:00BWUnited Therapeutics to Acquire Miromatrix Medical
11/10/202315:05GLOBEMiromatrix to Present at the 2023 ISODP Organ Donation..
05/10/202315:30GLOBEMiromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene..
06/9/202315:01GLOBEMiromatrix Announces Participation in H.C. Wainwright Global..
05/9/202315:04GLOBEMiromatrix Announces Participation in the ARM Tissue..
14/8/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:01EDGAR2Form 8-K - Current report
14/8/202315:01GLOBEMiromatrix Reports Second Quarter 2023 Results and Provides..
25/7/202315:01GLOBEMiromatrix to Report Second Quarter 2023 Financial Results
13/7/202315:01GLOBEMiromatrix Poster Voted Best in Congress at the 2023..
01/6/202315:01GLOBEMiromatrix Announces CEO Jeff Ross, Ph.D. will Expand His..
30/5/202315:08GLOBEMiromatrix Presenting at the 2023 American Transplant..
30/5/202315:05GLOBEMiromatrix Announces Participation in the 20th Annual..
11/5/202315:01GLOBEMiromatrix Reports First Quarter 2023 Results and Provides..

Su Consulta Reciente

Delayed Upgrade Clock